Peginterferon alfa-2b biosimilar (PanPharmaceuticals)

聚乙二醇干扰素α-2b生物类似药 (PanPharmaceuticals)

Report date: 2022/02/18 16:20:23

Base Information

Drug NamePeginterferon alfa-2b biosimilar (PanPharmaceuticals)
Drug Alias Name聚乙二醇干扰素α-2b生物仿制药 (PanPharmaceuticals)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsHepatitis C
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2010/12/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPanpharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesPanpharmaceuticals
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeL03AB10
Related LinksN/A